This Subcommittee is focused on modeling involving thrombosis, hemostasis, coagulation and fibrinolysis. It includes cellular, molecular, computational and pre-clinical in-vivo and in-vitro models.
Modeling a disease status is a challenge and most of the time can only be partially achieved. Understanding advantages and disadvantages of models lead us to an appropriate model selection. In addition, the standardization of current models and development of new models helps to improve science and expand the current knowledge.
If you are interested in the subcommittee and want to follow its activity, please click "join community" to participate.
Mandate
- To address issues of practical importance to the research community in the field.
- To evaluate existing data, determine issues for which data is missing or deficient, identify areas of controversy or pressing clinical need and discuss methodologic approaches to answer questions raised.
- To create international collaborations for the purpose of planning and executing projects related to the defined needs in the field.
- To suggest or organize collaborative studies as a result of these activities.
- To generate, publish and distribute reports, recommendations and other documents concerning the above.
- To develop laboratory standards, methods, and nomenclature if appropriate.
If you are a member of the Society and would like to know how to participate in the work of this group, please join the group to receive updates on activity or submit an Expression of Interest Form to the Chairman or any of the Co-Chairmen. We would be pleased to learn of your interest.
Leadership
- Chair - Laura Gutierrez
- Co-chair - Viviana Clavería
- Co-chair - Frederik Roland Denorme
- Co-chair - Steven Philip Grover
- Co-chair - Lacramioara Ivanciu
- Co-chair - Patricia Liaw
- Co-chair - Alexander Brill
- Co-chair - Robert Lee
- Co-chair - Ahmed Ghareeb
Projects:
Official Communications: